Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-002830

Chief Executive Officer acquired 1,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Climaco John M · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-28 Exercise or conversion : show line 1 in the form +1,250 46,260 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-28 Exercise or conversion : show line 2 in the form Restricted Stock Units −1,250 60,201 D
Loading xslF345X04/ownership.xml…